These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Inhibition of 5-HT3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells. Barann M; Bönisch H; Urban BW; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):145-52. PubMed ID: 9749998 [TBL] [Abstract][Full Text] [Related]
46. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity. Dhar AK; Mahesh R; Jindal A; Bhatt S Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677 [TBL] [Abstract][Full Text] [Related]
47. [Analysis of antiemetic effect of various dosage regimens of azasetron hydrochloride based on 5-HT3 receptor occupancy of serotonin]. Yamada Y; Fujita M; Okuyama K; Takayanagi R; Ozeki T; Yokoyama H; Iga T Yakugaku Zasshi; 2007 Feb; 127(2):353-7. PubMed ID: 17268155 [TBL] [Abstract][Full Text] [Related]
48. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors. Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097 [TBL] [Abstract][Full Text] [Related]
49. Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia. Schuhmacher A; Mössner R; Quednow BB; Kühn KU; Wagner M; Cvetanovska G; Rujescu D; Zill P; Möller HJ; Rietschel M; Franke P; Wölwer W; Gaebel W; Maier W Pharmacogenet Genomics; 2009 Nov; 19(11):843-51. PubMed ID: 19794330 [TBL] [Abstract][Full Text] [Related]
50. Noncompetitive Inhibition of 5-HT3 Receptors by Citral, Linalool, and Eucalyptol Revealed by Nonlinear Mixed-Effects Modeling. Jarvis GE; Barbosa R; Thompson AJ J Pharmacol Exp Ther; 2016 Mar; 356(3):549-62. PubMed ID: 26669427 [TBL] [Abstract][Full Text] [Related]
51. SR 57227A is a partial agonist/partial antagonist of 5-HT Nakamura Y; Kondo M; Koyama Y; Shimada S Biochem Biophys Res Commun; 2019 Jan; 508(2):590-596. PubMed ID: 30509492 [TBL] [Abstract][Full Text] [Related]
52. Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics. Haenisch B; Bönisch H Naunyn Schmiedebergs Arch Pharmacol; 2010 Jan; 381(1):33-9. PubMed ID: 20012264 [TBL] [Abstract][Full Text] [Related]
54. Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus. Mongeau R; De Montigny C; Blier P Eur J Pharmacol; 1994 Dec; 271(1):121-9. PubMed ID: 7698195 [TBL] [Abstract][Full Text] [Related]
55. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig. Lankiewicz S; Lobitz N; Wetzel CH; Rupprecht R; Gisselmann G; Hatt H Mol Pharmacol; 1998 Feb; 53(2):202-12. PubMed ID: 9463477 [TBL] [Abstract][Full Text] [Related]
56. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism. Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374 [TBL] [Abstract][Full Text] [Related]
57. RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors. Van Hooft JA; Vijverberg HP Eur J Pharmacol; 1997 Mar; 322(2-3):229-33. PubMed ID: 9098692 [TBL] [Abstract][Full Text] [Related]
58. Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders. Walstab J; Wohlfarth C; Hovius R; Schmitteckert S; Röth R; Lasitschka F; Wink M; Bönisch H; Niesler B Neurogastroenterol Motil; 2014 Jun; 26(6):810-20. PubMed ID: 24708203 [TBL] [Abstract][Full Text] [Related]
60. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]